{"id":"https://openalex.org/W4282959599","doi":"https://doi.org/10.1158/1538-7445.am2022-1236","title":"Abstract 1236: Biomarkers of response to abiraterone and the polo-like kinase 1 (PLK1) inhibitor onvansertib in metastatic castration resistant prostate cancer (mCRPC) patients","display_name":"Abstract 1236: Biomarkers of response to abiraterone and the polo-like kinase 1 (PLK1) inhibitor onvansertib in metastatic castration resistant prostate cancer (mCRPC) patients","publication_year":2022,"publication_date":"2022-06-15","ids":{"openalex":"https://openalex.org/W4282959599","doi":"https://doi.org/10.1158/1538-7445.am2022-1236"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2022-1236","doi":"https://doi.org/10.1158/1538-7445.am2022-1236","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2022-1236","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071752028","display_name":"Maya Ridinger","orcid":"https://orcid.org/0000-0001-5833-5573","observed_orcids":["https://orcid.org/0000-0001-5833-5573"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maya Ridinger","raw_affiliation_strings":["1Cardiff Oncology Inc., San Diego, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cardiff Oncology Inc., San Diego, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034230118","display_name":"Errin Samu\u00eblsz","orcid":"https://orcid.org/0000-0002-3424-7330","observed_orcids":["https://orcid.org/0000-0002-3424-7330"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Errin Samuelsz","raw_affiliation_strings":["1Cardiff Oncology Inc., San Diego, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cardiff Oncology Inc., San Diego, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008794938","display_name":"Peter J.P. Croucher","orcid":"https://orcid.org/0000-0003-1437-0224","observed_orcids":["https://orcid.org/0000-0003-1437-0224"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter J. Croucher","raw_affiliation_strings":["1Cardiff Oncology Inc., San Diego, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cardiff Oncology Inc., San Diego, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003109423","display_name":"Mark G. Erlander","orcid":"https://orcid.org/0000-0002-4231-7095","observed_orcids":["https://orcid.org/0000-0002-4231-7095"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark Erlander","raw_affiliation_strings":["1Cardiff Oncology Inc., San Diego, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cardiff Oncology Inc., San Diego, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053711811","display_name":"Katherine L. Ruffner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Katherine Ruffner","raw_affiliation_strings":["1Cardiff Oncology Inc., San Diego, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cardiff Oncology Inc., San Diego, CA;","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5031890333","display_name":"David Johnson Einstein","orcid":"https://orcid.org/0000-0001-9163-3281","observed_orcids":["https://orcid.org/0000-0001-9163-3281"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David J. Einstein","raw_affiliation_strings":["2Beth Israel Deaconess Medical Center, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Beth Israel Deaconess Medical Center, Boston, MA","institution_ids":["https://openalex.org/I1316535847"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"82","issue":"12_Supplement","first_page":"1236","last_page":"1236"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/abiraterone-acetate","display_name":"abiraterone","score":0.9610000252723694},{"id":"https://openalex.org/keywords/onvansertib","display_name":"onvansertib","score":0.9940000176429749},{"id":"https://openalex.org/keywords/plk1-inhibitors","display_name":"PLK1 inhibitors","score":0.843999981880188},{"id":"https://openalex.org/keywords/metastatic-castration-resistant-prostate-cancer","display_name":"metastatic castration-resistant prostate cancer","score":0.9610000252723694},{"id":"https://openalex.org/keywords/treatment-response-biomarkers","display_name":"treatment response biomarkers","score":0.777999997138977},{"id":"https://openalex.org/keywords/acquired-drug-resistance","display_name":"acquired drug resistance","score":0.777999997138977},{"id":"https://openalex.org/keywords/cell-free-dna","display_name":"cell-free DNA","score":0.6060000061988831},{"id":"https://openalex.org/keywords/pten-loss","display_name":"PTEN loss","score":0.7829999923706055},{"id":"https://openalex.org/keywords/mtor-signaling","display_name":"mTOR signaling","score":0.8159999847412109},{"id":"https://openalex.org/keywords/androgen-receptor-signaling","display_name":"androgen receptor signaling","score":0.625},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5370000004768372},{"id":"https://openalex.org/keywords/cell-cycle-regulation","display_name":"cell cycle regulation","score":0.3970000147819519},{"id":"https://openalex.org/keywords/gene-expression-signatures","display_name":"gene expression signatures","score":0.5770000219345093},{"id":"https://openalex.org/keywords/somatic-alterations","display_name":"somatic alterations","score":0.6010000109672546},{"id":"https://openalex.org/keywords/egfr","display_name":"EGFR","score":0.38999998569488525},{"id":"https://openalex.org/keywords/neurofibromatosis-type-1","display_name":"neurofibromatosis type 1","score":0.7829999923706055},{"id":"https://openalex.org/keywords/akt3","display_name":"AKT3","score":0.5580000281333923}],"concepts":[{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.8405932188034058},{"id":"https://openalex.org/C2777609662","wikidata":"https://www.wikidata.org/wiki/Q416356","display_name":"PTEN","level":4,"score":0.6625525951385498},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6622625589370728},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5392606854438782},{"id":"https://openalex.org/C61367390","wikidata":"https://www.wikidata.org/wiki/Q416601","display_name":"Androgen receptor","level":4,"score":0.48740819096565247},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4604440927505493},{"id":"https://openalex.org/C2777899217","wikidata":"https://www.wikidata.org/wiki/Q4759439","display_name":"Androgen deprivation therapy","level":4,"score":0.45237410068511963},{"id":"https://openalex.org/C162317418","wikidata":"https://www.wikidata.org/wiki/Q252857","display_name":"Transcriptome","level":4,"score":0.439301460981369},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.43443435430526733},{"id":"https://openalex.org/C2776551883","wikidata":"https://www.wikidata.org/wiki/Q1996756","display_name":"Enzalutamide","level":5,"score":0.4195343852043152},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.40692251920700073},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.3658999800682068},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.27624183893203735},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.19214677810668945},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.10705843567848206},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.07413163781166077},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2022-1236","doi":"https://doi.org/10.1158/1538-7445.am2022-1236","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2022-1236","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4250929564","https://openalex.org/W4213218344","https://openalex.org/W2954987754","https://openalex.org/W4254638511","https://openalex.org/W3178188792","https://openalex.org/W4280529461","https://openalex.org/W4309593095","https://openalex.org/W2793096203","https://openalex.org/W2921724894","https://openalex.org/W4221059008"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Abiraterone":[2],"(abi),":[3],"a":[4,35,64,316],"widely-used":[5],"standard":[6],"of":[7,41,106,167,174,228,262,297,320,346,373,397,420],"care":[8],"for":[9,129,354,424],"castration-sensitive":[10],"and":[11,54,90,120,164,202,238,240,250,258,341,401],"castration-resistant":[12],"prostate":[13,49,413],"cancers,":[14],"inhibits":[15],"the":[16,42,104,130,226,263,284,347,371,402,421],"androgen":[17],"receptor":[18],"signaling":[19,231,349],"pathway.":[20],"While":[21],"abi":[22,59,71,87,111,117],"slows":[23],"disease":[24,186],"progression,":[25],"extended":[26],"treatment":[27,175],"universally":[28],"results":[29],"in":[30,48,60,88,108,112,247,270,295,326,339,359,375,409],"acquired":[31],"resistance.":[32,72,118],"PLK1":[33,45,55,79],"is":[34,46,74,100],"serine/threonine":[36],"protein":[37],"kinase,":[38],"master":[39],"regulator":[40],"cell":[43,248],"cycle.":[44],"upregulated":[47],"cancer":[50,414],"following":[51],"androgen-deprivation":[52],"therapy":[53],"inhibition":[56],"synergizes":[57],"with":[58,86,110,115,225,243,362,377],"CRPC":[61,92],"models,":[62],"providing":[63],"potential":[65,352],"means":[66],"to":[67,102,125,180,279,356,369,399],"reverse":[68],"or":[69,273],"delay":[70],"Onvansertib":[73],"an":[75,293],"oral":[76],"highly":[77],"selective":[78],"inhibitor":[80,407],"that":[81,276,311,323,337],"showed":[82],"synergistic":[83],"anti-tumor":[84],"activity":[85,372],"in-vitro":[89],"in-vivo":[91],"models.":[93],"A":[94],"phase":[95],"2":[96,299],"clinical":[97],"trial":[98],"(NCT03414034)":[99],"ongoing":[101],"assess":[103,370],"efficacy":[105],"onvansertib":[107,408],"combination":[109,358,376],"mCRPC":[113,360],"patients":[114,168,181,201,209,216,266,309,313,328,361,416],"early":[116,363],"Genomic":[119,163,193],"transcriptomic":[121,165,302],"analyses":[122,303],"were":[123,178,195,277],"performed":[124,154,304],"identify":[126],"response":[127,398],"biomarkers":[128,353],"onvansertib/abi":[131,357,374],"combination.":[132],"Methods:":[133],"Cell-free":[134],"DNA":[135],"isolated":[136],"from":[137,198,307],"patient":[138,290],"plasma":[139],"was":[140,153,222,324],"analyzed":[141],"by":[142,158],"targeted":[143],"sequencing":[144],"using":[145,155],"Guardant":[146],"OMNI\u00ae":[147],"(500-gene":[148],"panel).":[149],"RNA":[150],"expression":[151,318],"profiling":[152],"archival":[156],"tissues":[157],"Veracyte":[159],"(formerly":[160],"Decipher":[161],"Biosciences).":[162],"profiles":[166,194],"who":[169,182],"progressed":[170],"within":[171],"12":[172,188],"weeks":[173,189],"(\u201cPD\u201d":[176],"patients)":[177],"compared":[179],"had":[183,210,267,292],"radiographic":[184],"stable":[185],"at":[187],"(\u201cSD\u201d":[190],"patients).":[191],"Results:":[192],"successfully":[196],"obtained":[197],"19":[199],"PD":[200,208,289,327],"31":[203,264],"SD":[204,215,221,265,312],"patients.":[205],"On":[206],"average,":[207],"more":[211],"somatic":[212],"alterations":[213,229,245,268,338],"than":[214],"(14":[217],"vs":[218],"7,":[219],"p=0.017).":[220],"positively":[223],"correlated":[224,242],"presence":[227],"affecting":[230],"pathways":[232],"such":[233,252],"as":[234,253],"MTOR,":[235,342],"NF1,":[236],"PTEN":[237,274,340],"EGFR,":[239],"negatively":[241],"gene":[244,317],"involved":[246],"migration":[249],"invasion":[251],"APC,":[254],"KDR,":[255],"PREX2,":[256],"NF2":[257],"AKT3.":[259],"Eight":[260],"(26%)":[261],"either":[269,296],"MTOR":[271],"(n=5)":[272,314],"(n=3),":[275],"predicted":[278],"have":[280],"functional":[281],"impacts":[282],"on":[283,305],"protein,":[285],"while":[286],"only":[287],"1":[288,405],"(5%)":[291],"alteration":[294],"those":[298],"genes.":[300],"Moreover,":[301],"tissue":[306],"8":[308],"revealed":[310],"exhibited":[315],"signature":[319],"\u201cPTEN":[321],"loss\u201d":[322],"absent":[325],"(n=3)":[329],"(p=0.016).":[330],"Conclusions:":[331],"Taken":[332],"together,":[333],"these":[334],"data":[335],"suggest":[336],"two":[343],"key":[344],"genes":[345],"PI3K":[348],"pathway,":[350],"are":[351,367],"sensitivity":[355],"abi-resistance.":[364],"Preclinical":[365],"studies":[366],"underway":[368],"PI3K-pathway":[378],"inhibitors.":[379],"Citation":[380],"Format:":[381],"Maya":[382],"Ridinger,":[383],"Errin":[384],"Samuelsz,":[385],"Peter":[386],"J.":[387,394],"Croucher,":[388],"Mark":[389],"Erlander,":[390],"Katherine":[391],"Ruffner,":[392],"David":[393],"Einstein.":[395],"Biomarkers":[396],"abiraterone":[400],"polo-like":[403],"kinase":[404],"(PLK1)":[406],"metastatic":[410],"castration":[411],"resistant":[412],"(mCRPC)":[415],"[abstract].":[417],"In:":[418],"Proceedings":[419],"American":[422],"Association":[423],"Cancer":[425,436],"Research":[426],"Annual":[427],"Meeting":[428],"2022;":[429],"2022":[430],"Apr":[431],"8-13.":[432],"Philadelphia":[433],"(PA):":[434],"AACR;":[435],"Res":[437],"2022;82(12_Suppl):Abstract":[438],"nr":[439],"1236.":[440]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2022-06-17T00:00:00"}